Nivolumab-induced new-onset seronegative rheumatoid arthritis in a patient with advanced metastatic melanoma: A case report and literature review
Immune-related adverse events have been reported in patients treated with anti-programmed death-1 receptor drugs such as nivolumab. We present a case of a new-onset seronegative rheumatoid arthritis in a patient with metastatic melanoma treated with nivolumab.
Enregistré dans:
Auteurs principaux: | Ammar Haikal, E Borba, Taqui Khaja, Gary Doolittle, Paul Schmidt |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2018
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/627788216e75443c974026dac7c3122c |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Comparison of Efficacy in Patients with Metastatic Melanoma Treated with Ipilimumab and Nivolumab Who Did or Did Not Discontinue Treatment Due to Immune-Related Adverse Events: A Real-World Data Study
par: Morten Fink, et autres
Publié: (2021) -
Nivolumab-Induced Exocrine Pancreatic Insufficiency
par: Boudewijn Sweep, et autres
Publié: (2021) -
Subjective sleep disturbances at the time of diagnosis in patients with polymyalgia rheumatica and in patients with seronegative elderly-onset rheumatoid arthritis. A pilot study
par: Ciro Manzo, et autres
Publié: (2020) -
Safety and efficacy of tocilizumab for rheumatoid arthritis: a systematic review and metaanalysis of clinical trial studies
par: Amal Saki, et autres
Publié: (2021) -
The onset of rheumatoid arthritis following trauma
par: Brawer AE, et autres
Publié: (2016)